Researchers used CRISPR to remove CD33 from donor stem cells, potentially giving doctors a way to attack aggressive blood cancers without destroying the healthy cells patients need after a transplant. In a 30-patient trial, the edited cells successfully took hold and appeared to shield blood cells from a CD33-targeted cancer treatment.
More in Research
This “rare” autism-linked genetic disorder may be far more common than scientists thought
September 25, 2026
CERN has begun disconnecting the Large Hadron Collider
September 25, 2026
Quantum computing’s “dark horse” just proved it can go universal
September 25, 2026
Earth is tearing apart beneath the Pacific Northwest
September 25, 2026
Scientists gave worms magnetic bacteria. They lived 43% longer
September 25, 2026
“We found something never seen before” – A dead star is producing a shock wave that shouldn’t exist
September 25, 2026
Latest News
'It's a big moment! | Putellas nets her first goal for London City
September 26, 2026
OpenAI pauses training of its ‘most capable models’
September 26, 2026
Fitzpatrick builds big lead at Open de France as Fleetwood withdraws
September 26, 2026
Wigan and Wakefield face off for Super League Grand Final spot LIVE!
September 26, 2026
தப்பி தவறி கூட.. தாய்லாந்து பக்கம் டூர் போயிடாதீங்க! பங்கமாகி கிடக்கும் பாங்காக்!
September 26, 2026
போர்க்களத்திற்கு வரும் புனிதர்களின் அழுகிய உடல் பாகங்கள்! உக்ரைனை ஜெயிக்க.. ரஷ்யாவின் புது ஐடியா!
September 26, 2026